St. Jude Medical seesaws on FDA warning letter

MassDevice.com Wall Street Beat

A warning letter from the FDA to St. Jude Medical (NYSE:STJ) sent the St. Paul, Minn.-based medical device company’s stock on a seesaw ride yesterday and today.

STJ shares closed up 1.5% yesterday at $38.85 each after St. Jude revealed the warning letter, but closed down 1.2% today at $38.39 apiece.

 

Sign up to get our free newsletters delivered straight to your inbox

St. Jude shrugged off the formal warning letter, which followed a so-called "Form 483" from the federal watchdog agency detailing 11 problems with quality control and documentation procedures at the Sylmar facility.

"As previously disclosed by management on its 3rd-quarter earnings call on Oct. 17, 2012, this warning letter was expected," St. Jude said today in a regulatory filing. "The FDA letter notes that it will not grant requests for exportation certificates to foreign governments or approve pre-market approval applications for Class III devices to which the quality system regulation deviations are reasonably related until the violations have been corrected. The warning letter does not, however, identify any specific concerns regarding the performance of, or indicate the need for any field or other action regarding, the Riata ST Optim or Durata leads or any other St. Jude Medical product," according to the filing. "Accordingly, the Company will continue manufacturing and shipping product from the Sylmar facility and customer orders are not expected to be impacted while we work to resolve the FDA’s concerns."

Last week, CEO Daniel Starks spent considerable energy trying to reassure investors at the J.P. Morgan healthcare conference about the problems in Sylmar, explaining why the Durata line was a sure thing, and why the Riata lead recall and FDA warnings related to a St. Jude manufacturing plant were no threat to the company’s hold on the larger ICD market.

The SEC filing made the same points, saying that St. Jude "has taken the appropriate regulatory circumstances into account in managing its business and setting investor expectations and believes the FDA’s concerns can be resolved without a material impact on the company’s financial results."

A week after Starks hipped investors to the possibility of a Form 483 in October, St. Jude revealed that the FDA came through on the threat, issuing a heavily redacted copy of the missive. A much less censored version made headlines the following month, disclosing further detail about the 11 problems found in Sylmar during FDA inspections from Sept. 25 to Oct. 17, 2012.

 Endostim raises $9M

Endostim raised $9.1 million of a hoped for $12 million from backers in 12 states for its implantable gastro-esophageal reflux disease device.

Read more

 Covidien closes CV Ingenuity buyout
Covidien (NYSE:COV) said it closed its buyout of CV Ingenuity and its drug-coated balloon platform.
Read more

 Given Imaging is off the auction block

Given Imaging (NSDQ:GIVN) says it’s taken itself off the auction block, prompting Discount Investment Corp. to say it’s putting its 46% stake up for sale.
Read more

 Stereotaxis regains NASDAQ’s good graces

Stereotaxis (NSDQ:STXS) said the NASDAQ stock exchange let it off the hook after a June 2012 de-listing warning after its market capitalization slipped below $15 million. Nevertheless, STXS shares closed down 10.3% today at $2.34 apiece.
Read more

 Analysts’ ups and downs

  • Abbott (NYSE:ABT): Barclays Equity Research initiates with "equal weight" rating, $35 price target.
  • Boston Scientific (NYSE:BSX): Credit Suisse upgrades from "neutral" to "outperform" rating, raises price target from $6 to $7.50.
  • C.R. Bard (NYSE:BCR): Bank of America/Merrill Lynch upgrades from "neutral" to "buy" rating, $114 price target; Leerink Swann maintains "market perform" rating, raises price target to $110-$115 from $98-$99.
  • Cerner (NSDQ:CERN): Sterne Agee Group reiterates "buy" rating, raises price target from $90 to $96.
  • Edwards Lifesciences (NYSE:EW): Zacks upgrades from “underperform” to “neutral” rating, $98 price target.
  • Haemonetics (NYSE:HAE): Zacks upgrades from "neutral" to an "outperform" rating, $50 price target.
  • Intuitive Surgical (NSDQ:ISRG): Lazard Capital upgrades from "neutral" to "buy" rating, $600 price target.
  • Medtronic (NYSE:MDT): TheStreet reaffirms "buy" rating.
  • Mindray (NYSE:MR): Goldman Sachs upgrades from “neutral” to “buy” rating.
  • NeuralStem (AMEX:CUR): Aegis Capital Corp. reiterates "buy" rating, raises price target from $3.50 to $4.
  • NxStage Medical (NSDQ:NXTM): Zacks raises from “neutral” to “outperform” rating, $14 price target.
  • Sirona Dental Systems (NSDQ:SIRO): Goldman Sachs downgrades from "buy" to "neutral" rating, $67 price target.
  • St. Jude Medical (NYSE:STJ): Barclays Equity Research reiterates"overweight/neutral" rating, $48 price target; BMO Capital Markets downgrades from "outperform" to "market perform" rating, raises price target from $38 to $40; Jefferies maintains "hold’ rating, raises price target to $39.
  • Varian Medical (NYSE:VAR): Lazard downgrades from "buy" to "neutral" rating.
  • Zimmer (NYSE:ZMH): Lazard downgrades from "buy" to "neutral" rating.

RSS From Medical Design & Outsourcing

  • Procyrion CEO discusses its life-changing pump designed to heal the heart
    Ben Hertzog is the CEO of Procyrion, a Houston-based company that is developing Aortix, a custom designed pump built around a powerful micro-motor mounted on a set of expandable struts. Aortix is designed to rest and heal the heart by reducing afterload and improving blood flow to vital organs. Unlike other circulatory assist devices that […]
  • U.S. Based Qure Medical Acquires UK-Headquartered Silicone Altimex
    Qure Medical, with corporate headquarters in Twinsburg, Ohio, has acquired UK-headquartered Silicone Altimex, announced Randy Ross, President and CEO of Qure Medical. Financial terms of the agreement were not disclosed. Qure Medical provides integrated elastomer solutions to medical device manufacturers. Silicone Altimex is one of Europe’s leading independent manufacturers of cleanroom-produced silicone tubing components and […]
  • Coatings2Go is issued U.S. Patent for hydrophilic coating
    Coatings2Go, a medical device coating supplier, recently announced its receipt of a patent as it relates to hydrophilic coatings. The U.S. Patent Office has issued to Coatings2Go a patent with a grant date of July 14, 2015: U.S. Patent Number 9,080,061, “Coating Resins And Coatings With Multiple Crosslink Functionalities.” “This new patent is the third […]
  • Herrmann Ultrasonics, Inc. announces its 25 Year Anniversary
    In 1990, Thomas Herrmann, the son of Walter Herrmann, who founded Herrmann Ultraschalltechnik GmbH in 1961, established Herrmann Ultrasonics Inc. in the Chicago area. Hermann Ultrasonics, Inc. is proud to recognize a milestone year in observance of their 25th anniversary. Herrmann Ultrasonics has been focused on providing ultrasonic welding technology for various markets such as […]
  • Consumer Health Applications receive the most attention today, but the future is elsewhere
    Wearables for health fall into a wide range of technologies, functions, use cases and over-arching regulatory frameworks that developers and prospective entrants have to understand in order to effectively compete. Using an underlying taxonomy for human health, we establish a health-focused wearables taxonomy around three major categories—applications, use cases, and form factors—the three areas critical […]
  • Paralyzed men move legs with new non-invasive spinal cord stimulation
    Five men with complete motor paralysis were able to voluntarily generate step-like movements thanks to a new strategy that non-invasively delivers electrical stimulation to their spinal cords, according to a new study funded in part by the National Institutes of Health. The strategy, called transcutaneous stimulation, delivers electrical current to the spinal cord by way […]
  • SCHURTER’s new power entry module offers IP 54 protection with V-Lock cord sets
    SCHURTER is pleased to announce, that its power entry module, series 5707, now offers IP 54 protection with V-Lock cord sets at the power input, in addition to IP 65 protection to the equipment. The sealed module is ideal for use in medical equipment exposed to leaks, drips and spills, as well as equipment subject […]
  • GlobTek presents its latest level VI AC/DC adapter and connverter
    T-43086-WWVV-X.X-Q Model is an addition to GlobTek’s Level VI compliant GT-43086 family and represents GlobTek’s 6 Watt wall plug-in series of AC/DC adapters (power supplies and chargers) with International Interchangeable blades. GlobTek’s changeable input blade system with individual field replaceable input plugs, including: North America and Japan NEMA 1-15P, Australian, UK BS 1363, European CEE […]
  • Sanmina’s familiarity with FDA gets skin treatment product to market fast
    The medical market for cosmetic devices is booming. However, quickly launching new products to meet demand is becoming more challenging because device manufactures face increased regulatory scrutiny. To help meet regulatory requirements, aesthetic and other medical-device OEMs are partnering with electronics manufacturing services (EMS) companies that also offer expertise with the FDA filings necessary to […]
  • Fluid connectors and quick disconnects for IVD equipment from CPC
    Colder Products Company (CPC) offers thousands of tubing connectors, quick disconnects and fittings for smart fluid handling in IVD and analytical equipment. Non-spill connectors speed testing throughput by eliminating drips, preventing air inclusion and increasing operator safety. Panel mount connectors can be added to existing equipment or bottle caps to provide secure, leak-free connections. Puncture […]
  • 310 Watt desktop medical power supply meets efficiency level VI requirements
    Power Partners releases a new 310 Watt medical grade desktop power supply from their PEAMD Series of AC and DC adapters. The 310 Watt unit is packed for ideal performance inside a compact case measuring 7.8 x 4 x 2 in. with a weight of only 3 lbs. The PEAMD310 Series is approved to the latest […]

Leave a Reply